BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6274140)

  • 21. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast.
    Seppälä M; Wahlström T; Bohn H
    Int J Cancer; 1979 Jul; 24(1):6-10. PubMed ID: 225283
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concanavalin A binding of pregnancy-specific beta-1-glycoprotein in normal pregnancy and trophoblastic disease.
    Koistinen R; Heikinheimo M; Rutanen EM; Stenman UH; Lee JN; Seppälä M
    Oncodev Biol Med; 1981; 2(3):179-82. PubMed ID: 6272237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental protein 5 in gestational trophoblastic disease: localization and circulating levels.
    Nisbet AD; Bremner RD; Horne CH; Brooker D; Twiggs LB; Okagaki T
    Am J Obstet Gynecol; 1982 Oct; 144(4):396-401. PubMed ID: 6289667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
    Hirashima N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A radioimmunoassay for pregnancy associated protein, beta 1SP1: levels in pregnancy, trophoblastic and neoplastic disease.
    Elvers LH; Hiemstra G; Lequin RM
    Horm Res; 1980; 12(5):245-52. PubMed ID: 6249709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pituitary gonadotropic function in uterine trophoblastic tumor].
    Lomonosova MV; Savinskaia AP; Molodyk AA; Gorshkova IA
    Med Radiol (Mosk); 1983 Aug; 28(8):40-4. PubMed ID: 6310308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC; Wong LC; Ma HK
    Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY
    Am J Obstet Gynecol; 1975 Oct; 123(3):291-8. PubMed ID: 170826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease.
    Osathanondh R; Berkowitz RS; de Cholnoky C; Smith BS; Goldstein DP; Tyson JE
    J Reprod Med; 1986 Mar; 31(3):179-83. PubMed ID: 3009803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trophoblastic beta 1-glycoprotein in the blood in trophoblastic tumors].
    Sokolov AV; Zhordaniia KI; Ledian KM
    Med Radiol (Mosk); 1983 Aug; 28(8):25-31. PubMed ID: 6310307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
    Miyamoto T
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):203-20. PubMed ID: 199477
    [No Abstract]   [Full Text] [Related]  

  • 40. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
    Horne CH; Rankin R; Bremner RD
    Int J Gynecol Pathol; 1984; 3(1):27-40. PubMed ID: 6203853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.